Withdrawal effects from GLP-1 medications include increased hunger, food preoccupation, and in some cases, rapid weight regain of 5-10% within the first few months off treatment
Typically, application of one 1mg dose once weekly constitutes the intermediate therapeutic dose for the restoration of physiological equilibrium during the escalation phase
5 out of 5 starsReviewed on 3/22/2025 Dr Gold is the best 5 out of 5 starsReviewed on 3/21/2025 Dr Gold always listen to your issue and comes up with a plan 5 out of 5 starsReviewed on 3/20/2025 Dr
This past June, the biotech giant published phase 2 results for MariTide (maridebart cafraglutide), a long-acting GLP-1 drug designed to be injected once a month rather than once a week
Tirzepatide (Mounjaro, Zepbound) Tirzepatide activates both GLP-1 and GIP receptors, providing stronger weight loss effects than semaglutide in head-to-head trials
Percent Daily Reference Intakes (RI) not established